Status: technology sold off
Agencourt Bioscience was developing a ‘sequencing-by-ligation’ system when they were acquired by Beckman in 2005. Beckman retained the sequencing services business, while Agencourt Personal Genomics was spun out to continue developing the NGS platform technology. APG was then acquired by ABI (now called Life Technologies) in 2006 for $120M. APG’s technology forms the basis of the sequencing chemistry which is now marketed by Life Technologies as SOLiD.
Please contact us at firstname.lastname@example.org if you have any information or opinions you’d like to share about this page.